Table 3.
Hemodynamic findings at baseline
| Propofol (n=20) | Sevoflurane (n=20) | |
|---|---|---|
| MAP (mmHg) | 109.5±13.9 | 107.7±12.3 |
| CVP (mmHg) | 5.8±2.8 | 5.4±2.0 |
| PMAP (mmHg) | 19.2±5.6 | 15.8±2.5 |
| PAWP (mmHg) | 9.8±3.5 | 8.5±2.5 |
| CI (L/min·m2) | 3.9±0.8 | 3.9±0.6 |
| RVEF (%) | 38.4±7.3 | 37.3±7.8 |
| RVSWI (g·m/m2) | 7.8±2.8 | 7.0±2.4 |
| RVEDVI (ml/m2) | 122.6±22.3 | 135.1±23.0 |
| GEDVI (ml/m2) | 755.5±132.8 | 832.8±152.1 |
| EVLWI (ml/kg) | 6.9±2.0 | 8.2±4.0 |
| OI (mmHg) | 425.7±41.5 | 427.8±74.0 |
| PVRI (dyn·s-1·cm-5) | 185.1±62.2 | 157.5±60.6 |
| Qs/Qt (%) | 12.8±3.2 | 13.6±3.6 |
Data were expressed as mean ± SD. There were no differences between two groups.